News for 'Sun Pharmaceuticals'

Over one-third Nifty50 stocks look weak on charts. Time to be cautious?

Over one-third Nifty50 stocks look weak on charts. Time to be cautious?

Rediff.com30 May 2023

The domestic benchmark indices - the S&P BSE Sensex and the National Stock Exchange Nifty50 - had lost close to 1.5 per cent in three days recently before gaining slightly. Notwithstanding weakness and volatility, the Nifty50 has managed to hold on to the 18,000 mark, while the Sensex has managed to stay above the 61,000 level. The performance of the stocks that comprise these front-line indices remains polarised.

Ethical Code to keep doctor, drugmaker nexus at bay not mandatory yet

Ethical Code to keep doctor, drugmaker nexus at bay not mandatory yet

Rediff.com22 Aug 2022

'Gift-giving' - from free dinners and drug samples to promotional merchandise - seems to be driving drugmakers' marketing - a marketing prescription deeply entrenched in the industry. This is a well-oiled racket that sees pharmaceutical (pharma) companies 'gifting' doctors to push their respective drugs under the guise of marketing. But is there a cure in sight to end this unhealthy alliance? The recent controversy following the income-tax raids on Bengaluru-based drugmaker Micro Labs, makers of popular paracetamol brand Dolo-650, has brought this to the fore, again.

Watch Live! All the action in Parliament

Watch Live! All the action in Parliament

Rediff.com2 Dec 2021

On Day 4 of Winter Session, Lok Sabha will discuss the 'COVID-19 pandemic and various aspects related to it'.

'Technology' appears 44 times in Modi-Biden statement, up from 5 three years ago

'Technology' appears 44 times in Modi-Biden statement, up from 5 three years ago

Rediff.com24 Jun 2023

From the seas to the stars, this partnership will now be deepened by the defining role of technology, the statement said.

Central panel to study WHO report on deaths linked to Indian syrups

Central panel to study WHO report on deaths linked to Indian syrups

Rediff.com12 Oct 2022

They said after examining and analysing the adverse event reports, causal relationship and all related details shared by or to be shared by the WHO, the committee will advise and recommend further course of action to the Drugs Controller General of India (DCGI).

Three scientists share Nobel Prize for 'Click Chemistry'

Three scientists share Nobel Prize for 'Click Chemistry'

Rediff.com5 Oct 2022

The Royal Swedish Academy of Sciences on Wednesday awarded the Nobel Prize in Chemistry 2022 to Carolyn R Bertozzi, Morten Meldal and K Barry Sharpless.

India Needs Insulation From Grey Rhinos

India Needs Insulation From Grey Rhinos

Rediff.com27 Jun 2023

India must be prepared to deal with climate disasters, geopolitical confrontations, and social strife linked to global events, asserts Jayant Sinha, chairman of Parliament's Standing Committee on Finance.

Rupee @ 80: Forex deficit to hurt India Inc's margins

Rupee @ 80: Forex deficit to hurt India Inc's margins

Rediff.com28 Jul 2022

The rupee breached the 80-mark against the dollar on Tuesday. The steady depreciation in the value of the rupee against the US dollar is likely to prove expensive for corporate India. The listed companies' revenue expenses in foreign currency or imports exceed their export revenues or revenue earnings in forex. In their latest financial year, BSE500 companies, excluding banks and non-banking finance companies and insurance (BFSI), reported combined forex expenses of Rs 12.31 trillion against forex earnings of around Rs 10 trillion.

India's personal data protection bill may threaten innovation, growth: USTR

India's personal data protection bill may threaten innovation, growth: USTR

Rediff.com29 Apr 2022

The US on Thursday raised concerns over India's Personal Data Protection (PDP) Bill and draft non-personal data governance framework, claiming these could potentially threaten innovation and economic growth. In its latest 'Special 301' Report, the US Trade Representative (USTR) kept India on the priority watch list, maintaining the country remains one of the world's most challenging major economies with respect to protection and enforcement of intellectual property (IP). In December 2021, a joint parliamentary committee released a report recommending changes to the PDP Bill, 2019, that could undermine important IP protections in India.

3 employees of Noida pharma arrested in Uzbek cough syrup death case

3 employees of Noida pharma arrested in Uzbek cough syrup death case

Rediff.com3 Mar 2023

Three employees of a Noida-based pharmaceutical firm, whose cough syrup is alleged to have led to the death of 18 children in Uzbekistan last year, were arrested on charges of manufacturing and sale of adulterated drugs, officials said.

Centre seeks info from embassy on Iran's bar on rice, tea imports

Centre seeks info from embassy on Iran's bar on rice, tea imports

Rediff.com8 Dec 2022

The department of commerce has urged the agriculture ministry as well as the diplomatic mission in Tehran to apprise it of details as to why Iranian buyers have stopped import of rice and tea from India, a senior government official said. Exporters said that exports of items such as high quality tea and rice have stopped since last week. As of now, there has been no confirmation from the authorities and the response from the embassy in Tehran is also taking time, they said.

Mandatory RT-PCR tests for passengers from China, 4 other nations

Mandatory RT-PCR tests for passengers from China, 4 other nations

Rediff.com24 Dec 2022

Any passenger from these countries found symptomatic or testing positive for coronavirus would be quarantined, Mandaviya said.

Exports rise to record high of $418 bn in FY22

Exports rise to record high of $418 bn in FY22

Rediff.com3 Apr 2022

India's merchandise exports spurted to a record high of $418 billion in the 2021-22 fiscal on higher shipments of petroleum products, engineering goods, gem and jewellery and chemicals, according to official data released on Sunday. Outbound shipments touched an all-time high of $40 billion in a month in March 2022, Commerce and Industry Minister Piyush Goyal told reporters. Exports stood at $34 billion in March 2021.

Govt ramps up Remdesivir production to 74 lakh vials

Govt ramps up Remdesivir production to 74 lakh vials

Rediff.com23 Apr 2021

The Union home ministry said several steps have been taken to augment the production and supply of Remdesivir injections from 38.80 lakh units per month to 74 lakh units per month by early next month, and asked the states to ensure its seamless supply and transport.

'There is clearly a 17 - 18% upside in the markets over the next 12-15 months'

'There is clearly a 17 - 18% upside in the markets over the next 12-15 months'

Rediff.com5 Apr 2023

Earnings growth, attractive valuations and change in FPI flows from negative to positive over the next 12 months are some of the key triggers for an upside. "A poor monsoon, high inflation and further rate hike are some of the key risks

Pharma co mired in syrup deaths shuts production at Noida unit

Pharma co mired in syrup deaths shuts production at Noida unit

Rediff.com30 Dec 2022

The move has come days after the state government announced to form a special investigation team to probe into the death of Disha Salian, the former manager of late actor Sushant Singh Rajput.

Don't ignore any notes shared by NSCS, NSA: Modi to ministers, officials

Don't ignore any notes shared by NSCS, NSA: Modi to ministers, officials

Rediff.com2 Oct 2022

Stressing that while framing any policy, there is a need to look at it from India's strategic point of view, Modi said there were instances when notes from the national security council were not given due importance.

Should you opt to buy stocks of Divis Labs?

Should you opt to buy stocks of Divis Labs?

Rediff.com21 Apr 2023

The stock of Divis Laboratories is up 10 per cent over the last couple of trading sessions on expectations that the worst is behind and the company could see a sequential growth in the March quarter of the 2022-23 financial year (Q4FY23). The stock witnessed the highest downgrades among Nifty50 index stocks with earnings cuts over a third after the Q3FY23 results. The company had posted a 32 per cent drop in revenues over the year ago quarter in Q3FY23 and 8 per cent sequentially, which was sharply lower than Street expectations.

Centre remains on high-alert for new Covid variants

Centre remains on high-alert for new Covid variants

Rediff.com20 Jun 2023

COVID-19 is on the verge of becoming endemic but Indian scientists are keeping a close watch on each new variant and the government would continue to maintain a high alert, Union health minister Mansukh Mandaviya has said, underlining that the virus has managed to survive and is going to stay.

Pharma funds: 'Enter with a horizon of 5-7 years or more'

Pharma funds: 'Enter with a horizon of 5-7 years or more'

Rediff.com14 Mar 2023

In contrast with their strong performance in 2020 and 2021, pharmaceutical and healthcare funds experienced a decline in 2022, with returns plummeting by an average 9.8 per cent. This trend has continued in the current year, with year-to-date return remaining in the negative (-4.9 per cent). In the past three months, pharma funds have been hit hard, experiencing a 7.9 per cent decline.

'Whatever we do, we have to make an impact'

'Whatever we do, we have to make an impact'

Rediff.com26 Jun 2023

'Professors can teach even when they are 90 because they don't lose their skill with words. Go deeper and there's spirituality in it.'

'Build portfolio in mid-, small caps via SIPs'

'Build portfolio in mid-, small caps via SIPs'

Rediff.com11 May 2023

'As the Indian economy continues to expand over the next three years, mid- and small-caps should do well as they have higher exposure to the domestic economy than large-caps.'

Mask mandate to continue in India amid new variant threat

Mask mandate to continue in India amid new variant threat

Rediff.com18 Oct 2022

Mandaviya reviewed the pandemic situation, status of vaccination drive and the global scenario of new variants of Covid.

50 million doses of Covaxin set to expire in 2023

50 million doses of Covaxin set to expire in 2023

Rediff.com6 Nov 2022

Nearly 50 million doses of Bharat Biotech's COVID-19 vaccine, Covaxin lying with the firm are set to expire early next year as there are no takers owing to poor demand, company sources said.

Capex Crosses Rs 6 Trillion In December

Capex Crosses Rs 6 Trillion In December

Rediff.com10 Jan 2023

'If private capex has to kick in, there should at least be 2-3 years of visibility.'

After 80 km chase, gunman kills Indian-origin pharma CEO for US$ 10k

After 80 km chase, gunman kills Indian-origin pharma CEO for US$ 10k

Rediff.com30 Oct 2021

The "wealthy pharmaceutical executive" was followed for 50 miles (80 kms) from a Pennsylvania casino to his New Jersey home where he was murdered in an attempted robbery while his wife and daughter were sleeping, the New York Post newspaper quoted the police as saying.

Will KCR's BRS Make Any Impact In National Politics?

Will KCR's BRS Make Any Impact In National Politics?

Rediff.com24 Oct 2022

Maharashtra is the BRS' first target.

Pharma industry posts 51.5% growth in April sales

Pharma industry posts 51.5% growth in April sales

Rediff.com8 May 2021

When compared to the domestic sales of April 2019, the growth is around 37 per cent. However, compared to the previous month (March), the growth is 18.4 per cent.

'Markets Won't Enter Bear Territory Anytime Soon'

'Markets Won't Enter Bear Territory Anytime Soon'

Rediff.com23 Mar 2023

'Markets could face uncertainty in the short to medium term.' 'It would be prudent to invest in alternative asset classes, especially debt, for about a year.' 'Bank fixed deposits are offering rates as high as 9 per cent per annum and these can be used as a great hedging tool until equity markets stabilise.'

'Fed rate cut appears unlikely'

'Fed rate cut appears unlikely'

Rediff.com17 Mar 2023

'The Fed rate will peak in the range of 5.1-5.3 per cent during the second quarter of CY23 and will most likely stay there for a while before rate cuts start in CY24.'

Bharat Biotech cancels Covaxin deals with Brazil firms after graft row

Bharat Biotech cancels Covaxin deals with Brazil firms after graft row

Rediff.com23 Jul 2021

The termination of the MoU came after the deal with the Brazilian government for supply of 20 million doses of the vaccine landed in controversy and attracted investigation by authorities in that country.

'We have overloaded the unstable Himalayas'

'We have overloaded the unstable Himalayas'

Rediff.com26 May 2023

'And Joshimath has already shown the dangers ahead.' 'We have to acknowledge that our mountains are still young babies.' 'You don't put an extra load on the back of a growing child!'

Prices of key Covid bulk drugs shoot up as demand rises

Prices of key Covid bulk drugs shoot up as demand rises

Rediff.com12 May 2021

The API of Paracetamol, a fever and pain medication, has grown 25 per cent from Rs 450-480 per kg in December 2020 to Rs 580-600 per kg in April. When compared to the pre-Covid prices of December 2019, the surge is much steeper -- around 140 per cent, reports Sohini Das.

Uncertain future awaits Indian pharma exporters

Uncertain future awaits Indian pharma exporters

Rediff.com25 Aug 2021

As uncertainty looms large in Afghanistan, Indian pharma exporters are apprehensive to send goods to the war-torn country and the target of exporting $126 million worth of pharmaceutical goods to the Taliban-ruling nation now depends on the future outcome. Udaya Bhaskar, director general of Pharmaceuticals Export Promotion Council of India (Pharmexcil) body under the Department of Commerce on Tuesday said as the situation is grim over there and India pharma exporters have cordial relations with Afghanistan. "The projected target for 2021-22 is $126.22 million.

Amid rise in Covid cases, Centre prohibits exports of Remdesivir

Amid rise in Covid cases, Centre prohibits exports of Remdesivir

Rediff.com11 Apr 2021

Remdesivir is considered a key anti-viral drug in the fight against Covid-19. In addition, the government has taken three steps to ensure easy access of hospitals and patients to Remdesivir.

Bombed Out Ukraine

Bombed Out Ukraine

Rediff.com21 Apr 2022

A drone shot shows the massive Komodor logistics park in ruins after being bombed and burnt near Makariv. The Russian attack in early March destroyed some $50 million of medicines and medical raw materials for the Ukrainian pharmaceutical company Farmac, according to Forbes magazine.

Exports record flat growth; trade deficit widens in Nov

Exports record flat growth; trade deficit widens in Nov

Rediff.com15 Dec 2022

India's exports recorded a flat growth of 0.59 per cent to $31.99 billion in November, even as trade deficit widened to $23.89 billion during the month, according to the data released by the government on Thursday. Exports stood at $31.8 billion in November last year. Imports rose by 5.37 per cent to $55.88 billion in November as compared to $53.03 billion in the corresponding month a year ago, the data showed. During April-November 2022, exports rose by 11 per cent to $295.26 billion as against $265.77 billion in the same month last year.

Exports up 2.14% in July; trade deficit at record $30 bn

Exports up 2.14% in July; trade deficit at record $30 bn

Rediff.com12 Aug 2022

India's exports rose by 2.14 per cent to $36.27 billion in July while the trade deficit almost tripled to $30 billion during the month due to over 70 per cent rise in crude oil imports, according to official data released on Friday. Imports shot up by 43.61 per cent to $66.27 billion in the month compared to July 2021, the data showed. The trade deficit was $10.63 billion in July 2021.

JD-U nominates Nitish Kumar's trusted aide Anil Hegde to RS

JD-U nominates Nitish Kumar's trusted aide Anil Hegde to RS

Rediff.com16 May 2022

Bihar Chief Minister Nitish Kumar's Janata Dal-United on Monday announced its low-profile top office-bearer Anil Hegde as its candidate for the by-election to a Rajya Sabha seat which has been necessitated by the death of multiple-term MP, King Mahendra.

Exports decline sharply in Oct; trade deficit widens

Exports decline sharply in Oct; trade deficit widens

Rediff.com15 Nov 2022

India's exports entered negative territory after a gap of about two years, declining sharply by 16.65 per cent to $29.78 billion in October, mainly due to global demand slowdown, even as trade deficit widened to $26.91 billion, according to data released by the commerce ministry on Tuesday. Key export sectors, including gems and jewellery, engineering, petroleum products, ready-made garments of all textiles, chemicals, pharma, marine products, and leather, recorded negative growth during October. Imports during the month under review rose by about 6 per cent to $56.69 billion on account of increase in the inbound shipments of crude oil and certain raw materials such as cotton, fertiliser and machinery.